Search results
AstraZeneca withdrawing Covid vaccine, months after admitting rare side effect
The Telegraph via Yahoo News· 43 minutes agoThe Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, months after the pharmaceutical...
Pfizer (PFE) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 6 days agoWe recently received the first U.S. FDA gene therapy approval for Pfizer with FDA approval for Beqvez, a one-time gene therapy for adults with hemophilia...
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
CNBC· 6 hours agoThe injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24,...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 6 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...
Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans
FierceBiotech· 6 days agoPfizer’s 2024 revival tour is off and running, but the Big Pharma remains mum on one critical...
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 5 days agoWithin minutes of getting the Johnson & Johnson Covid-19 vaccine, Michelle Zimmerman felt pain...
ESCMID 2024: Highlights on prophylaxis and treatment of infectious diseases
Clinical Trials Arena via Yahoo Finance· 6 days agoThis was compared to 67.2% efficacy for RSV and 78.8% efficacy for severe RSV in adults who had...
Enanta Pharmaceuticals Inc (ENTA) (Q2 2024) Earnings Call Transc
Guru Focus· 2 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Enanta Pharmaceuticals Inc (ENTA, Financial) is advancing its virology and immunology pipeline ...
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
FOX21 Colorado Springs· 11 hours ago...neoadjuvant UM Phase 2 investigator-sponsored trial on June 3rd, and targeting neoadjuvant UM update in over 30 patients from Phase 2 company-sponsored trial and regulatory guidance both in H2 2024Selected move-forward Phase 2 dose for IDE397 in MTAP squamous NSCLC, based on clinical efficacy...
Earnings call: Enanta Pharmaceuticals Q2 fiscal results and pipeline updates By Investing.com
Investing.com· 4 hours agoEnanta Pharmaceuticals (NASDAQ: NASDAQ:ENTA), a biopharmaceutical company focused on developing oral...
